Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: New York NY, Palisades Park NJ, Greenwich CT,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: New York NY, Palisades Park NJ, Greenwich CT,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Staten Island NY, New York NY, Hackensack NJ,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for
Esophageal Squamous Cell Carcinoma
Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644781

Phase 3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: New York NY, The Bronx NY, Florham Park NJ,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Sayre PA,
Sponsor: Altesa Biosciences, Inc.

Sex: All

Age: 40 - 70+

Code: NCT07610395

Phase 2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Brooklyn NY, New York NY, The Bronx NY, Laurelton NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: New York NY, Brooklyn NY, Toms River NJ,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase 3, Recruiting

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

for
Major Depressive Disorder (MDD)
Location: New York NY, Brooklyn NY, Marlton NJ, Cromwell CT,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT07226661

Phase 2, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: Long Island City NY, Warren Township NJ, Eatontown NJ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase 3, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: New York NY, Summit NJ, Albany NY, Silver Spring MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase 3, Recruiting

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: New York NY, Hackensack NJ, New Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06564038

Phase 1, Phase 2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: New York NY, Hackensack NJ, Montreal, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase 1, Phase 2, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: New York NY, Manhasset NY, New Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

for
Major Depressive Disorder
Location: New York NY, Staten Island NY, Brooklyn NY,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06223880

Recruiting

A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

for
Attention-deficit/Hyperactivity Disorder,
Location: New York NY, Cherry Hill NJ, Boston MA, Watertown MA,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18 - 65

Code: NCT07759154

Phase 3, Recruiting

A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: New York NY, Cherry Hill NJ, The Bronx NY, Jamaica NY,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT07767903

Phase 3, Recruiting

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

for
Psychosis Associated With Alzheimer's Disease
Location: New York NY, West Long Branch NJ, Toronto,
Sponsor: MapLight Therapeutics

Sex: All

Age: 55 - 70+

Code: NCT06887192

Phase 2, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New York NY, New Brunswick NJ, New Haven CT, Newark DE,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for
Binge-Eating Disorder
Location: New York NY, Mount Kisco NY, Princeton NJ,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT06413433

Phase 3, Recruiting